Here’s what drug makers don’t want you to know about PBMs
Pharmacy benefit managers shield patients from higher drug prices, but drug makers don’t want you to know that.
Read MoreStrategies to Encourage the Adoption of Biosimilars
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Read MoreDrug Lists 101 – Supporting Access to Safe and Effective Medications
Drug formularies are critical to combat the estimated $16 billion wasted each year on low value drugs that do not improve health outcomes.
Read MoreBoosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read MoreExpress Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read MoreDiscount Programs Encourage Patient Affordability and Access
Express Scripts works across the health care industry to forge innovative partnerships, while making sure members are not missing out on potential prescription cost savings.
Read MoreExpress Scripts in 2023: Supporting clients, patients, and health plans
Over the last 12 months, Express Scripts has rolled out numerous groundbreaking programs and projects. Learn about some of the most notable advancements and innovations of 2023.
Read MoreBiosimilars 101
To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.
Read More